Stock APLM APOLLOMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Apollomics, Inc.

Equities

APLM

KYG0411D1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-14 pm EDT 		5-day change 1st Jan Change
0.201 USD -2.24% Intraday chart for Apollomics, Inc. -6.51% -79.17%
Jun. 04 Apollomics Announces Vebreltinib Data At the 2024 American Society of Clinical Oncology Annual Meeting CI
May. 08 Apollomics, Inc. Appoints Robert Lin to the Board of Directors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
APOLLOMICS, INC. Stock Apollomics, Inc.
 22.06M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.22B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.02B -
  1. Stock Market
  2. Equities
  3. APLM Stock
  4. Charts Apollomics, Inc.
  5. Sector Chart